Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future therapeutic developments of estrogen use

H Fillit1

  • 1Henry L. Schwartz Department of Geriatrics and Adult Development, Mount Sinai Medical Center, New York, New York 10029, USA.

Journal of Clinical Pharmacology
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges and opportunities for novel combination therapies in Alzheimer's disease: a report from the EU/US CTAD Task Force.

The journal of prevention of Alzheimer's disease·2025
Same author

Alzheimer's Disease Linkage to Real-World Evidence (AD-LINE) Study: Linking Claims Data to Phase 3 GRADUATE Study of Gantenerumab.

The journal of prevention of Alzheimer's disease·2024
Same author

Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force.

The journal of prevention of Alzheimer's disease·2023
Same author

Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force.

The journal of prevention of Alzheimer's disease·2022
Same author

Standardizing Electronic Health Record Data on AD/ADRD to Accelerate Health Equity in Prevention, Detection, and Treatment.

The journal of prevention of Alzheimer's disease·2022
Same author

Using Digital Tools to Advance Alzheimer's Drug Trials During a Pandemic: The EU/US CTAD Task Force.

The journal of prevention of Alzheimer's disease·2021

Estrogen replacement therapy (ERT) shows promise for improving cognitive function and preventing dementia in postmenopausal women. Further research is needed to clarify its role in managing menopausal cognitive dysfunction and Alzheimer's disease.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Gerontology

Background:

  • Estrogen replacement therapy (ERT) is established for osteoporosis and heart disease prevention.
  • Emerging research explores ERT's neurobiological effects on cognitive function and dementia.
  • Menopause is linked to cognitive and affective dysfunction, potentially mitigated by ERT.

Purpose of the Study:

  • To investigate the role of ERT in cognitive function and dementia prevention in aging women.
  • To explore the neurobiological mechanisms underlying estrogen's effects on the brain.
  • To address key clinical questions regarding ERT for menopausal cognitive issues and neurodegenerative diseases.

Main Methods:

  • Review of experimental evidence and clinical trials on ERT and cognitive function.

Related Experiment Videos

  • Epidemiological studies examining long-term ERT effects on late-life cognition.
  • Analysis of neurochemical, vascular, and free radical mechanisms of estrogen action.

    • Main Results:

    • Estrogen loss is associated with cognitive decline, including menopausal dysfunction and senile dementia.
    • ERT has demonstrated improvements in cognitive and affective function in some studies.
    • Estrogen may act as a neuronal growth factor and influence neurochemistry and vasculature.

    Conclusions:

    • Estrogen's impact on cognitive function and dementia warrants further investigation.
    • Clinical trials are needed to define optimal ERT strategies for cognitive and affective disorders.
    • Understanding estrogen's vascular effects is crucial for Alzheimer's and vascular dementia research.